Maze Therapeutics MAZE
NASDAQ MAZE
$32.58 +0.13 (+0.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Assets (2024 - 2026)

Updated

Maze Therapeutics (MAZE) posted Assets of $531.63 million for Q2 2026, up 75.2% from $303.52 million a year earlier and up 26.7% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics' Assets came in at $397.13 million, up 65.1% from FY2024.

  • In prior years, Maze Therapeutics' Assets was $240.54 million in FY2024.
  • On a year-over-year basis, Assets has increased in each of the last three quarters.
  • According to Business Quant data, Assets for the three prior quarters was $419.71 million (Q1 2026), $397.13 million (Q4 2025) and $422.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Maze Therapeutics 1.92 Bn 434.24 Mn - 531.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 531.63 Mn
Mar 31, 2026 419.71 Mn
Dec 31, 2025 397.13 Mn
Sep 30, 2025 422.06 Mn
Jun 30, 2025 303.52 Mn
Mar 31, 2025 332.84 Mn
Dec 31, 2024 240.54 Mn
API Access

Maze Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=MAZE&period=max&api_key=YOUR_API_KEY